SIR 2024
Interventional Oncology
Nicholas Fidelman, MD
Professor
University Of California San Francisco
Disclosure information not submitted.
Rana Rabei, MD
Resident
University of California, San Francisco
Disclosure information not submitted.
Neuroendocrine tumors (NETs) pose unique challenges due to their diverse origins and clinical presentations. Liver metastases are common and significantly impact patients' quality of life and prognosis. The integration of liver-directed therapies and systemic treatments has become a cornerstone of NET management. This educational abstract aims to provide a comprehensive overview of the current state of LDT, with a particular focus on the intricate interplay between LDT and PRRT.
Clinical Findings/Procedure Details: This presentation will delve into various aspects of LDT and PRRT: